approval
saveAFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approval
community read0 votes
Sponsor: MANNKIND. Form: POWDER. Route: INHALATION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalAFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approvalJan 23, 2026 · 252d ago
- approvalAFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approvalFeb 3, 2023 · 1337d ago
- approvalAFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approvalOct 25, 2018 · 2899d ago
- approvalAFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approvalApr 24, 2018 · 3083d ago
- approvalAFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approvalSep 29, 2017 · 3290d ago
- approvalAFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approvalApr 7, 2016 · 3830d ago
- approvalAFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approvalFeb 17, 2016 · 3880d ago
- approvalAFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approvalSep 16, 2015 · 4034d ago
comments(0)
5-min edit window · permanent after that